As an organisation dedicated to promoting and protecting the health, rights, and dignity of all individuals, IPPF must prioritise the safety and well-being of our community in every space we occupy. After careful consideration, we have decided to leave the platform X, effective 20 January 2025. Unfortunately, X no longer provides the safe and supportive environment that our community deserves. The increasing prevalence of harmful discourse and the platform's failure to adequately address it have made this decision necessary. We are also deeply concerned about Meta’s new policy updates announced in the beginning of January, which raise critical questions about privacy, misinformation, and the safety of vulnerable groups online, including women, migrants, transgender people and the LGBTQIA+ community. As advocates for sexual and reproductive health and rights, we must ensure the digital spaces we engage with uphold the values of equity, inclusion, and accountability. The growing public outcry over censorship and restricted exposure to critical topics, such as Palestine-related content, on platforms like Meta and X, highlights the urgent need for transparency, equity, and fairness in digital spaces. These principles remain central to our advocacy. Our commitment to creating meaningful conversations and driving positive change remains steadfast. You can continue to connect with IPPF European Network on LinkedIn, via our new Bluesky account, or the IPPF EN website, where we will remain active and responsive.  We thank you for your continued support and invite you to join us in advocating for safer and more equitable digital spaces for all. Together, we can build a world where everyone can thrive—online and offline. #DigitalSafety      

The recent decision to indefinitely ban the private prescription of puberty blockers for trans youth in the UK marks a profoundly troubling development in the ongoing struggle for the rights of trans people and access to necessary, life-saving and evidence-based healthcare. In the UK, where no form of trans-specific healthcare is currently available for minors through the NHS and waiting lists have reached 6 years, this decision constitutes a de facto ban on puberty blockers. This decision, which overrides years of established medical guidance and expertise, is deeply political, rooted in a divisive public discourse and misinformation rather than the recommendations of leading medical authorities. It threatens the well-being of vulnerable trans youth, whose lives depend on timely, supportive, and individualised healthcare. ILGA-Europe, IPPF European Network, TGEU, IGLYO, and The Kite Trust call on the UK government to reconsider this harmful decision and to engage meaningfully with both the medical and scientific community and civil society groups representing the interests of trans youth and trans adults.  The framing and justification for this ban have leaned heavily on a polarised and often misleading public narrative about trans identities and related trans healthcare and epistemologically and methodologically questionable studies about trans identities and trans-specific healthcare. Despite claims of prioritising child safety, this decision disregards the consensus of medical professionals and organisations such as the World Professional Association for Transgender Health (WPATH) and the Endocrine Society’s Clinical Practice Guideline, which have long endorsed puberty blockers as a safe and reversible option for managing gender dysphoria in minors. These treatments allow young people experiencing distress with their assigned gender to pause puberty, giving them time to better understand their needs and identity, without the added pressure of physical changes brought on by puberty.[1] The political instrumentalisation of healthcare for trans minors has become a rallying point for anti-trans rhetoric, which often conflates all trans-specific healthcare with irreversible medical interventions. This characterisation is not only inaccurate but also deeply harmful. Puberty blockers do not lead to permanent medical transition [2] – they are a widely used and reversible treatment prescribed for various conditions, including precocious puberty.[3] By banning them for trans youth specifically, the UK government is singling out a vulnerable group for discriminatory and harmful treatment based on ideology rather than evidence. Misinformation about the nature and effects of puberty blockers has played a significant role in shaping public opinion and policy. Opponents of trans-specific healthcare frequently cite exaggerated or unfounded claims about the risks of these treatments, ignoring the robust body of research demonstrating their safety and efficacy. Long-term studies show that puberty blockers and other trans-specific healthcare significantly reduce rates of depression and suicidality among trans youth [4] — outcomes that align with broader understandings of the critical importance of affirming care for marginalised populations. Expert voices, including paediatric endocrinologists, psychologists, and trans health specialists, have been sidelined in favour of rhetoric that frames trans-specific healthcare as controversial. This erasure of medical expertise undermines the principles of patient-centred care and puts the health of trans youth at risk. The decision to ban puberty blockers ignores the individualised, case-by-case assessments that qualified professionals conduct before prescribing such treatments,[5] opting instead for an unyielding prohibition that strips both doctors and families of agency. The consequences of this ban will be devastating. For many trans youth, the ability to access puberty blockers represents a lifeline. Denying them this care will force young people to undergo the changes of puberty associated with their assigned gender, exacerbating gender dysphoria and increasing risks of mental health struggles, including anxiety, depression, and suicidal tendencies. By removing a critical tool for early intervention, this decision condemns trans youth to unnecessary suffering and places an already marginalised group at greater risk of harm. Furthermore, this policy undermines the trust between trans individuals and the healthcare system. Families seeking support for their children will face increased barriers, uncertainty, and stigma, while healthcare providers may find themselves unable to offer the care they know to be best for their patients. These ripple effects extend beyond trans youth, chilling the broader provision of trans-specific healthcare and reinforcing a climate of fear and hostility. Trans children and young people deserve safety, understanding, and access to the same standard of care afforded to their peers. Decisions about their healthcare should be guided by medical evidence and the expertise of trained professionals, not by political agendas. The indefinite ban on puberty blockers represents a failure to prioritise the rights and well-being of trans youth, and it sets a dangerous precedent for further erosion of the rights of LGBTI persons in the UK.  We urge policymakers to reconsider this harmful decision and to engage meaningfully with both the medical and scientific community and civil society groups representing the interests of trans youth and trans adults. Upholding the dignity and humanity of trans youth requires a commitment to evidence-based healthcare, free from the distortions of ideology and misinformation. Only by centering the voices and needs of trans youth can we hope to build a society that values and protects all its members.   Signatories ILGA Europe IPPF European Network TGEU IGLYO The Kite Trust   *** 1. Cal Horton, Experiences of puberty and puberty blockers: Insights from trans children, trans adolescents, and their parents, Vol. 39(1), Journal of Adolescent Research, available at: https://journals.sagepub.com/doi/full/10.1177/07435584221100591v.  2. Hannema et al, Endocrine management of transgender and gender diverse adolescents: expert opinion of the ESPE Working Group on Gender Incongruence and the Endo-ERN main thematic group on Sexual Development and Maturation, available at: https://pubmed.ncbi.nlm.nih.gov/39622214/. 3. Giordano & Holm, Is puberty delaying treatment ‘experimental treatment’?, Vol 21(2) International Journal of Transgender Health (2020). 4. Van der Miesen et al, Psychological Functioning in Transgender Adolescents Before and After Gender-Affirmative Care Compared with Cisgender General Population Peers, Vol 66(6) Journal of Adolescent Health (2020); Olson et al, Mental Health of Transgender Children Who Are Supported in Their Identities, Vol 137(3) Pediatrics (2016); Nath, R., Matthews, D.D., DeChants, J.P., Hobaica, S., Clark, C.M., Taylor, A.B., Muñoz, G. (2024). 2024 U.S. National Survey on the Mental Health of LGBTQ+ Young People. West Hollywood, California: The Trevor Project. www.thetrevorproject.org/survey-2024. 5. Cass, Hilary (2024), Independent review of gender identity services for children and young people: Final report, pp. 168-169, available at: https://cass.independent-review.uk/home/publications/final-report/    *** Photo credit: Elina Emurlaev, UnSplash

Civil society organisations unite today to put forward our shared vision for the future of gender equality in the European Union (EU). We call on the EU to work over the next five years towards the practical realisation of a Union where everyone can live in safety, free from discrimination and violence, and where gender equality is not just an aspiration but a lived reality for all - regardless of their gender, ethnicity, race, gender identity and expression, sexual orientation, sex characteristics, disability, residence status, social class, age, among others. The last mandate saw notable initiatives to advance gender equality. However, despite these achievements, striking inequalities remain. As the new European Commission is taking office, we request the EU institutions and Member States to redouble their efforts and to ensure that advancing gender equality remains a key priority mainstreamed throughout EU laws and policies for the next 5 years, with the necessary resources allocated. In particular, we call on the EU to ensure the highest level of ambition is reflected in the upcoming Roadmap for Women’s Rights and the Gender Equality Strategy post-2025, particularly geared towards achieving the following objectives (download the joint statement below for our detailed asks): Realising the full range of women’s rights: Upholding sexual and reproductive health and rights (SRHR) Combating the backlash against gender equality Protecting Women Human Rights Defenders and their organisations Ending sexual and gender-based violence: Implementing the EU Directive combating violence against women and domestic violence (VAW)  Going beyond the Directive on VAW Responding to intersectional discrimination and oppression Ensuring sufficient funding for these objectives Our call to action: We urge the EU institutions and Member States to join us in building a more just and equal society. Gender equality must remain a top priority in all EU policy processes over the next five years. Let us work together to ensure that women and girls in all their diversity in the EU can live free from violence, discrimination, and oppression.  Signatories: AGE Platform Europe Amnesty International Center for Reproductive Rights EL*C - Eurocentralasian Lesbian* Community End FGM European Network European Sex Workers Rights Alliance IGLYO ILGA-Europe International Planned Parenthood Federation European Network (IPPF EN) La Strada International - European NGO Platform against Human Trafficking Platform for International Cooperation on Undocumented Migrants (PICUM) Protection International Organisation Intersex International Europe - OII Europe

On 3 December, Norway took a major step closer to reproductive freedom when its Parliament adopted by a large majority a groundbreaking new law extending self-determined abortion rights from 12 weeks to 18. "This is significant progress for sexual and reproductive health and rights (SRHR) in Norway, and reflects the growing global trend toward liberalizing abortion access. Over the past 30 years, more than 60 countries have expanded abortion rights, and this move demonstrates Norway’s commitment to reproductive autonomy and gender equality​.” said Kjersti Augland, assistant general manager with Sex og Politikk, IPPF’s Member Association in Norway. “The fact that the new law in Norway uses inclusive, gender-neutral language needs to be highlighted and celebrated. It will ensure that all pregnant people—regardless of gender—can access abortion care, recognizing diverse identities and experiences,” said Micah Grzywnowicz, the Regional Director of IPPF European Network. The new law will assess the accessibility of abortion care within the primary health care system, since until now, abortions have only been accessible at regional hospitals. Sex og Politikk will follow implementation closely, holding the government accountable for ensuring equitable access, emphasizing that most abortions today are performed using medication, making it feasible for primary healthcare providers to provide this care. Advocates continue to call for abortion care to be accessible, compassionate, and tailored to people’s needs regardless of location​. Regrettably, abortion review boards will still exist, creating unnecessary obstacles and delays for people needing care beyond 18 weeks, and forcing them to defend their right to access care. Sex og Politikk and its partners are committed to ensuring that future revisions of Norway’s abortion law address these concerns and further dismantle barriers to care. This moment represents not just a legislative milestone, but a call to continue advocating for full reproductive freedom in Norway.   Photo by Maryan Ivasyk on Unsplash

IPPF European Network warmly welcomes the coming into force on 1 December of a new law that introduces legal protections and labour rights for sex workers in Belgium. This is a major step forward in Belgian sex workers’ long-running campaign for greater safety and freedom, following their victory in securing decriminalisation of sex work in 2022. It is also the first case in Europe of a country introducing a legal framework aimed at safeguarding sex working people and guaranteeing their employment rights. “Decriminalization of all aspects of sex work, together with social policies that address structural inequalities, is the only way that countries can protect the health, safety and lives of sex workers. With this new law, Belgium continues to lead the way,” said Micah Grzywnowicz, Regional Director of IPPF EN. The new law, adopted by the Belgian Parliament in May 2024, applies to people who carry out sex work as employees. It aims to reduce discrimination by ensuring that - like those who work in any other sector - sex workers have access to social security, including health insurance, annual leave, sick and maternity leave, unemployment benefits and pension rights. It also enshrines freedoms and protections that safeguard sex workers’ health and safety. These include people’s right to refuse a client, to refuse a sexual act, to set the conditions of a sexual act and to end a sexual act at any moment, safe from fear of being fired. The law mandates criminal record checks for employers and obliges them to put in place safety measures for the people they employ. “We congratulate the Belgian government for the steps it has taken together with sex worker organisations, in a process that has been guided by our expertise,” said Sabrina Sanchez, Coordinator of ESWA, the European Sex Workers‘ Rights Alliance . “Decriminalisation is not perfect and this law is just the beginning of broader labour rights for sex workers in Belgium; it may need to be strengthened in future. We will continue to share our knowledge and experience to ensure that we have a good model in Belgium that can also be an example to other countries on how to progress towards the decriminalisation of sex work and the achievement of labour rights for sex workers,” added Sanchez. “IPPF EN applauds sex workers in Belgium for their leadership in the fight for social justice, first through decriminalisation in 2022, and now with the introduction of the specific legal framework needed to begin delivering concrete change in people’s lives,” said Micah Grzywnowicz. *** More information on the new law here via UTSOPI, the Belgian Union of Sex Workers *** IPPF EN is a proud supporter of ESWA. We are opposed to any measures in EU policy or legislative instruments that would criminalise any aspect of sex work, including clients and third parties, in line with IPPF’s global policy position and allyship with sex worker communities.  

IPPF EN, together with around 80 civil society organisations, healthcare professionals and academics working to advance women’s rights and the rights of LGBTI people, address letter to President von der Leyen to express our deep concern at the long delay in the publication of the European Commission Recommendation on the prevention of harmful practices against women and girls. We urge the current Commission to adopt the Recommendation swiftly or guarantee its adoption by the next Commission before 2025, in line with the clear commitments made under the Gender Equality Strategy and the LGBTIQ Equality Strategy 2020-2025. We strongly support the adoption of this Recommendation, which will provide effective guidance for Member States on ways to address various harmful practices, including those committed to in the Gender Equality Strategy 2020-2025 and in the LGBTIQ Equality Strategy 2020-2025. Furthermore, we call on the Commission to ensure all forms of obstetric and gynaecological violence, mistreatment and abuse are included in this Recommendation. We strongly believe this Recommendation would fill a critical gap and make a substantial contribution towards protecting women and girls in all their diversity from all forms of harm in the EU. Please read the full letter below.